hims & hers glp 1 Despite the Stigma, Isn't Backing Away From Weight-Loss Drugs Hims & Hers Selling GLP-1

A 2026 analysis in the Journal of Medical Internet Research found real-world discontinuation rates far exceed clinical trial numbers, with up to 70% of patients stopping treatment within 24 months -- often because of these effects

Compounds: CJC-1295 + Ipamorelin

Symptoms often include fatigue, lightheadedness, pale skin, shortness of breath, and cognitive fog

Ipamorelin acts on ghrelin receptors as a GHRP, while Sermorelin and Tesamorelin act as GHRH analogs

10.1038/s41591-019-0423-5 299 WeiZ.SongJ.WangG.CuiX.ZhengJ.TangY.et al

This triple-agonist mechanism allows it to target multiple metabolic pathways simultaneously for enhanced weight loss and metabolic benefits